Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application
Loading...
Date
Authors
Gaitanis, G.
Nomikos, K.
Vava, E.
Alexopoulos, E. C.
Bassukas, I. D.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Type
Type of the conference item
Journal type
peer-reviewed
Educational material type
Conference Name
Journal name
J Eur Acad Dermatol Venereol
Book name
Book series
Book edition
Alternative title / Subtitle
Description
BACKGROUND/AIM: Theoretical considerations support the combination of cryosurgery and topical imiquimod to treat basal cell carcinomas (BCC). The aim of the present study was to test the feasibility and efficacy of 'cryosurgery during continued imiquimod application' ('immunocryosurgery') to treat 'high-risk-for-recurrence' BCCs. METHODS: Thirteen patients with 21 biopsy-proven tumours (4 of 21 relapses after prior surgery) were included. After 2-5 weeks (median, 3) of daily 5% imiquimod cream application, the tumours were treated by liquid N(2) cryosurgery (spray, two cycles, 10-20 s) and imiquimod was continued for additional 2-12 weeks (median, 4). The outcome after at least 18 months of follow-up (18-24 months) is currently reported. RESULTS: Nineteen of 21 tumours responded promptly to immunocryosurgery; two tumours required additional treatment cycles to clear. Thus, the clinical clearance rate was 100%. Only 1 of 21(5%) tumour relapsed after at least 18 months of follow-up (cumulative efficacy: 95%). CONCLUSIONS: 'Immunocryosurgery' is a promising non-surgical combination modality to treat 'high-risk-for-recurrence BCCs'. Initial evidence is suggestive of an at least additive effect of the two combined modalities. Further studies comparing immunocryosurgery directly with cryosurgery and imiquimod monotherapies will confirm the reported results.
Description
Keywords
Aged, Aged, 80 and over, Aminoquinolines/administration & dosage/*therapeutic use, Antineoplastic Agents/administration & dosage/*therapeutic use, Carcinoma, Basal Cell/drug therapy/*surgery, Combined Modality Therapy, Cryosurgery/*methods, Feasibility Studies, Female, Humans, Male, Pilot Projects, Prospective Studies, Skin Neoplasms/drug therapy/*surgery
Subject classification
Citation
Link
http://www.ncbi.nlm.nih.gov/pubmed/19555364
http://onlinelibrary.wiley.com/store/10.1111/j.1468-3083.2009.03224.x/asset/j.1468-3083.2009.03224.x.pdf?v=1&t=h0ta075s&s=d843d7add337f42ef41b07df05a694c2e14f6a63
http://onlinelibrary.wiley.com/store/10.1111/j.1468-3083.2009.03224.x/asset/j.1468-3083.2009.03224.x.pdf?v=1&t=h0ta075s&s=d843d7add337f42ef41b07df05a694c2e14f6a63
Language
en
Publishing department/division
Advisor name
Examining committee
General Description / Additional Comments
Institution and School/Department of submitter
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής